Syros to Participate in TD Cowen 44th Annual Health Care Conference
Syros Pharmaceuticals CEO to Participate in Panel Discussion at TD Cowen 44th Annual Health Care Conference
02/27/2024 - 07:00 AM
CAMBRIDGE, Mass. --(BUSINESS WIRE)--
Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced that its Chief Executive Officer, Conley Chee, will participate in a panel discussion at the TD Cowen 44th Annual Health Care Conference. Management will also be available for one-on-one meetings. Details are as follows:
TD Cowen 44th Annual Health Care Conference
Date: Tuesday, March 5
Boston, MA
A live webcast of the panel discussion will be available on the Investors & Media section of the Syros website at www.syros.com . An archived replay of the webcast will be available for approximately 30 days following the live event.
About Syros Pharmaceuticals
Syros is committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies. Driven by the motivation to help patients with blood disorders that have largely eluded other targeted approaches, Syros is developing tamibarotene, an oral selective RARα agonist in frontline patients with higher-risk myelodysplastic syndrome and acute myeloid leukemia with RARA gene overexpression. For more information, visit www.syros.com and follow us on Twitter (@SyrosPharma ) and LinkedIn .
View source version on businesswire.com: https://www.businesswire.com/news/home/20240227887206/en/
Syros Contact
khunady@syros.com
Investor Contact
hannah.deresiewicz@sternir.com
Source: Syros Pharmaceuticals
When will the CEO of Syros Pharmaceuticals participate in a panel discussion?
Conley Chee, the CEO of Syros Pharmaceuticals, will participate in a panel discussion at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5.
Where will the panel discussion take place?
The panel discussion will take place at the Boston Marriott Copley Place in Boston, MA.
How can investors watch the panel discussion?
Investors can watch the live webcast of the panel discussion on the Investors & Media section of the Syros website at www.syros.com.
Will there be a replay of the webcast available?
Yes, an archived replay of the webcast will be available for approximately 30 days following the live event.
Syros Pharmaceuticals Inc.
SYRS Rankings
#4660 Ranked by Stock Gains
SYRS Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Biotechnology, Manufacturing, Pharmaceutical Preparation Manufacturing
Country
US
City
Cambridge
About SYRS
syros pharmaceuticals is a life sciences company that is focused on treating disease by mapping gene regulatory circuits and modulating the factors that regulate gene expression. syros has pioneered world-leading gene control research and drug discovery capabilities with a proven ability to integrate disease biology and genomic data--a proficiency that is not well represented in pharmaceutical r&d. central to the syros approach is a proprietary platform of carefully integrated assay technologies, bioinformatics, and biologic insights developed by members of syros' senior leadership. while this scientific approach has applications in many therapeutic areas, syros has demonstrated success initially in oncology, where it may help address numerous unmet medical needs.
